RO7617991 / Roche - LARVOL DELTA

A Study of RO7617991 in Patients With Locally Advanced or Metastatic MAGE-A4-Positive Solid Tumors (clinicaltrials.gov) - P1 | N=0 | Withdrawn | Sponsor: Genentech, Inc. | N=210 ➔ 0 | Recruiting ➔ Withdrawn

Enrollment change • Metastases • Trial withdrawal • Oncology • Solid Tumor